Keith S. Manchester, Director at Roivant Sciences Ltd. (ROIV), sold 3,114,228 shares at $22.93 ($71.8M) on 2025-12-16, disclosed to the SEC on 2025-12-18.
Open-market sale of $71.8M ROIV by Director. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $22.93 | 275,000 | $6.3M | 8.8% |
| 2 | $23.08 | 642,282 | $14.8M | 20.6% |
| 3 | $23.08 | 642,282 | $14.8M | 20.6% |
| 4 | $23.02 | 155,076 | $3.6M | 5.0% |
| 5 | $23.02 | 155,076 | $3.6M | 5.0% |
| 6 | $23.05 | 432,718 |
| $10.0M |
| 13.9% |
| 7 | $23.05 | 432,718 | $10.0M | 13.9% |
| 8 | $23.17 | 189,538 | $4.4M | 6.1% |
| 9 | $23.17 | 189,538 | $4.4M | 6.1% |
| Total | $23.06 avg | 3,114,228 | $71.8M | 100% |
| Filing → |
| ROIV | SELL | 2025-11-21 | $29.8M | — | Filing → |
| ROIV | SELL | 2024-09-26 | $11.7M | — | Filing → |
| ABUS | SELL | 2024-08-16 | $33K | — | Filing → |